Ijeoma Edoka

1.1k total citations
36 papers, 581 citations indexed

About

Ijeoma Edoka is a scholar working on Economics and Econometrics, Epidemiology and Health. According to data from OpenAlex, Ijeoma Edoka has authored 36 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 10 papers in Epidemiology and 9 papers in Health. Recurrent topics in Ijeoma Edoka's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Vaccine Coverage and Hesitancy (8 papers) and Global Maternal and Child Health (7 papers). Ijeoma Edoka is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Vaccine Coverage and Hesitancy (8 papers) and Global Maternal and Child Health (7 papers). Ijeoma Edoka collaborates with scholars based in South Africa, United Kingdom and United States. Ijeoma Edoka's co-authors include Nicholas Stacey, Barbara McPake, Karen Hofman, Shu Wen Ng, Paul Ramchandani, Stavros Petrou, Tim Ensor, Anthony Scott, Corné van Walbeek and Barry M. Popkin and has published in prestigious journals such as Social Science & Medicine, Journal of Affective Disorders and Vaccine.

In The Last Decade

Ijeoma Edoka

34 papers receiving 567 citations

Peers

Countries citing papers authored by Ijeoma Edoka

Since Specialization

Citations

This map shows the geographic impact of Ijeoma Edoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ijeoma Edoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ijeoma Edoka more than expected).

Fields of papers citing papers by Ijeoma Edoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ijeoma Edoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ijeoma Edoka. The network helps show where Ijeoma Edoka may publish in the future.

Co-authorship network of co-authors of Ijeoma Edoka

This figure shows the co-authorship network connecting the top 25 collaborators of Ijeoma Edoka. A scholar is included among the top collaborators of Ijeoma Edoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ijeoma Edoka. Ijeoma Edoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure 2025 ·Nature Reviews Nephrology ·(unknown), Panji Fortuna Hadisoemarto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ijeoma Edoka, Valérie A. Luyckx, Martin I. Meltzer, Yot Teerawattananon	0
2	Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report 2024 ·LSHTM Research Online (London School of Hygiene and Tropical Medicine) ·Rebecca A. Clark, (unknown), (unknown), (unknown), (unknown), Rupali J. Limaye, Birgitte Giersing, Lewis K. Schrager, Gérald Voss, Edine Tiemersma, Mike Frick, Ijeoma Edoka, Alemnew F. Dagnew, (unknown), (unknown), (unknown), Richard G. White	1
3	Extended cost-effectiveness analysis of interventions to improve uptake of diabetes services in South Africa 2024 ·Health Policy and Planning ·(unknown), Isabelle Feldhaus, Ijeoma Edoka, Alisha N. Wade, Ciaran Kohli‐Lynch, (unknown), Stéphane Verguet	1
4	Costs of the COVID-19 vaccination programme: estimates from the West Rand district of South Africa, 2021/2022 2024 ·BMC Health Services Research ·Ijeoma Edoka, (unknown), (unknown), (unknown), (unknown), (unknown), Heena Brahmbhatt, Pedro T. Pisa, Gesine Meyer‐Rath, Jacqui Miot	2
5	A cost-effectiveness analysis of South Africa’s COVID-19 vaccination programme 2024 ·Vaccine ·Ijeoma Edoka, Sheetal Silal, Lise Jamieson, Gesine Meyer‐Rath	1
6	Pancreatic cancer mortality in South Africa: A case-control study 2023 ·South African Medical Journal ·(unknown), Ijeoma Edoka, Eustasius Musenge	1
7	Costs of seasonal influenza vaccination in South Africa 2022 ·Influenza and Other Respiratory Viruses ·(unknown), (unknown), Ciaran Kohli‐Lynch, (unknown), Stefano Tempia, Meredith McMorrow, Philipp Lambach, (unknown), Cheryl Cohen, Raymond Hutubessy, Ijeoma Edoka	6
8	Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021 2022 ·Vaccine X ·Karoun H. Bagamian, Chloe Puett, John Anderson, Farzana Muhib, Clint Pecenka, Jere R. Behrman, Robert F. Breiman, Ijeoma Edoka, Susan Horton, Gagandeep Kang, Karen L. Kotloff, Claudio F. Lanata, James A Platts-Mills, Firdausi Qadri, Elizabeth T. Rogawski McQuade, Christopher R. Sudfeld, Pascale Vonaesch, Thomas F. Wierzba, (unknown)	5
9	Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa 2021 ·Open Forum Infectious Diseases ·Youngji Jo, Lise Jamieson, Ijeoma Edoka, Lawrence Long, Sheetal Silal, Juliet R.C. Pulliam, Harry Moultrie, Ian Sanne, Gesine Meyer‐Rath, Brooke E Nichols	33
10	Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System 2021 ·International Journal of Health Policy and Management ·Ijeoma Edoka, (unknown), Lise Jamieson, Gesine Meyer‐Rath, (unknown)	23
11	Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates 2021 ·PharmacoEconomics ·Laura C. Edney, Derek Lomas, Jonathan Karnon, Laura Vallejo‐Torres, Niek Stadhouders, (unknown), Mike Paulden, Ijeoma Edoka, Jessica Ochalek	20
12	Influenza economic burden among potential target risk groups for immunization in South Africa, 2013–2015 2020 ·Vaccine ·Stefano Tempia, Jocelyn Moyes, Adam L. Cohen, Sibongile Walaza, Meredith McMorrow, Ijeoma Edoka, (unknown), Florette K. Treurnicht, Orienka Hellferscee, Nicole Wolter, Anne von Gottberg, Johanna M. McAnerney, Halima Dawood, Ebrahim Variava, Cheryl Cohen	4
13	A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme 2020 ·Vaccine ·Ijeoma Edoka, Ciaran Kohli‐Lynch, (unknown), (unknown), Stefano Tempia, Meredith McMorrow, (unknown), Philipp Lambach, Raymond Hutubessy, Cheryl Cohen	19
14	Influenza disease burden among potential target risk groups for immunization in South Africa, 2013–2015 2020 ·Vaccine ·Stefano Tempia, Sibongile Walaza, Jocelyn Moyes, Meredith McMorrow, Adam L. Cohen, Ijeoma Edoka, (unknown), Florette K. Treurnicht, Orienka Hellferscee, Nicole Wolter, Anne von Gottberg, Johanna M. McAnerney, Halima Dawood, Ebrahim Variava, Cheryl Cohen	8
15	The Impact of Leaving Camps on Well‐being of Internally Displaced Persons in Northern Uganda 2019 ·South African Journal of Economics ·(unknown), Barbara McPake, Ijeoma Edoka	1
16	Sugar-based beverage taxes and beverage prices: Evidence from South Africa's Health Promotion Levy 2019 ·Social Science & Medicine ·Nicholas Stacey, (unknown), Shu Wen Ng, Corné van Walbeek, Karen Hofman, Ijeoma Edoka	56
17	Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015 2019 ·Influenza and Other Respiratory Viruses ·Stefano Tempia, Jocelyn Moyes, Adam L. Cohen, Sibongile Walaza, Ijeoma Edoka, Meredith McMorrow, Florette K. Treurnicht, Orienka Hellferscee, Nicole Wolter, Anne von Gottberg, (unknown), Johanna M. McAnerney, Halima Dawood, Ebrahim Variava, Cheryl Cohen	28
18	Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa 2019 ·Value in Health Regional Issues ·Abualbishr Alshreef, (unknown), Bryony Dawkins, (unknown), Sue Ward, David Meads, Matthew Taylor, Simon Dixon, Anthony J. Culyer, Francis Ruiz, Kalipso Chalkidou, Ijeoma Edoka	11
19	Changes in catastrophic health expenditure in post-conflict Sierra Leone: an Oaxaca-blinder decomposition analysis 2017 ·International Journal for Equity in Health ·Ijeoma Edoka, Barbara McPake, Tim Ensor, (unknown), (unknown)	26
20	Universal health coverage reforms: implications for the distribution of the health workforce in low-and middle-income countriess 2014 ·WHO South-East Asia Journal of Public Health ·Ijeoma Edoka, Barbara McPake	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact